mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-06 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-06 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-06 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
8e-06 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-05 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |